ReviewBMJ (Clinical research ed.)2005
Recent developments in bisphosphonates for patients with metastatic breast cancer.
Review in BMJ (Clinical research ed.), 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Quality of life issues in patients with bone metastases: A systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023Pooled it
- 125I brachytherapy in the palliation of painful bone metastases from lung cancer after failure or rejection of conventional treatments.Oncotarget · 2016Trial
- From Technological Innovation to Clinical Translation: Progress and Challenges in 3D Bioprinting for the Development of Breast Cancer Bone Metastasis Models.Advanced healthcare materials · 2026Review
- Multifunctional Peptide-Based Biohybrid for Targeted Reduction of Metastatic Breast Carcinoma-Associated Osteolysis.Journal of functional biomaterials · 2025Article
- Anti‑metastatic activity of aromatic aminomethylidenebisphosphonates in a mouse model of 4T1 cell‑derived breast cancer.Oncology reports · 2023Article
- Mechanisms Supporting the Use of Beta-Blockers for the Management of Breast Cancer Bone Metastasis.Cancers · 2021Review
- Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG ZAMBONEY sub-study.Journal of bone oncology · 2015Article
- Image-guided cryoablation for the treatment of painful musculoskeletal metastatic disease: a single-center experience.Skeletal radiology · 2014Article
- The role of the bone microenvironment in skeletal metastasis.Journal of bone oncology · 2013Review
- Optimising the use of bone-targeted agents in patients with metastatic cancers: a practical guide for medical oncologists.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2011Review
- Bone pain reduction in patients with metastatic breast cancer treated with ibandronate-results from a post-marketing surveillance study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2010Article
- Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma.British journal of cancer · 2010Article
- Skeletal-related events (SREs) in breast cancer patients with bone metastases treated in the nontrial setting.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2010Article
- Automated CT-based analysis to detect changes in the prevalence of lytic bone metastases from breast cancer.Clinical & experimental metastasis · 2009Article
- A primer of bone metastases management in breast cancer patients.Current oncology (Toronto, Ont.) · 2008Article
- Comparing the results of bisphosphonate use in clinical trials with actual practice: a case of apples and oranges?Current oncology (Toronto, Ont.) · 2006Article
- Ibandronic acid: a review of its use in the treatment of bone metastases of breast cancer.Drugs · 2006Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.